Clinical Trials Browser

Phase 3 × Has results × trifluridine tipiracil drug combination × Clear all

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

NCT04457297 2026-01-21

ALTAIR

Phase 3 Completed

243 enrolled 13 charts

Gastrointestinal

Digestive System Diseases, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Colorectal Neoplasms

NCT05064059 2025-09-17

MK-4280A-007

Phase 3 Completed

441 enrolled 24 charts

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

NCT04737187 2024-09-24

SUNLIGHT

Phase 3 Completed

492 enrolled 22 charts 1 FDA

Gastrointestinal

Colorectal Neoplasms

NCT01607957 2024-09-19

RECOURSE

Phase 3 Completed

800 enrolled 12 charts

Gastrointestinal

Colorectal Neoplasms

NCT02500043 2024-09-03

Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer

Phase 3 Completed

507 enrolled 17 charts 1 FDA

Gastrointestinal

Stomach Neoplasms

NCT05223673 2024-08-20

COLSTAR

Phase 3 Terminated

7 enrolled 12 charts

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT01955837 2020-11-17

TERRA

Phase 3 Completed

406 enrolled 22 charts

Gastrointestinal

Colorectal Neoplasms

Clinical Trials

MK-7902-017

ALTAIR

MK-4280A-007

SUNLIGHT

RECOURSE

Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer

COLSTAR

TERRA